entertainment -WSS

entertainment

author：leisure time 2025-10-02 21:06:56 - browse：39886

STAT

What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Virtual Event: March of the Biosimilars

hotspot

leisure time

WSS

The stability of $0 premiums in Medicare Advantage

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

CDC picks Alphabet's Verily for wasterwater surveillance contract

Asbestos, a deadly carcinogen, banned by EPA

Flu, Covid vaccination rates decline, new survey data show

leisure time

entertainment

focus

Anesthesiologist group: stop taking Ozempic before surgery

Lawsuit highlights wrinkle for disputes over surprise medical bills

ChatGPT in medicine: STAT answers readers' burning questions

AstraZeneca to buy developer of next

Medicare details structure of new drug price negotiation program

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The United States is paying nearly triple for new Covid vaccines

The cancer drug shortage isn’t new — and neither are the solutions

CVS Caremark has created a new ploy: the drug ‘rebate credit’

knowledge

Some top drug companies are starting to take action on climate

Virtual Event: March of the Biosimilars

Stop Congress from blocking public access to science

Plastic surgeons increase patient psychiatric screenings

Plastic surgeons increase patient psychiatric screenings

6 solutions to address cancer drug shortages and others

hotspot

focus

leisure time

hotspot